Gilead Sciences
Price & Volume
Stats
See more52W Range | $59.82-$119.12 |
Market Cap | $132.7B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $28.7B |
Revenue Growth (YoY) | 6.4% |
Gross Profit (12 Mos) | $22.5B |
Diluted EPS | $0.39 |
News
See moreYahoo Finance • 16 days ago
1 Healthcare Stock to Target This Week and 2 to Turn Down
Yahoo Finance • 27 days ago
Why Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest In
Yahoo Finance • 2 months ago
European Medicines Agency Validates Gilead’s Marketing Authorization Application and EU-Medicines for All Application for Twice-Yearly Lenacapavir for HIV Prevention
Yahoo Finance • 2 months ago
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.79
About
CEO | Mr. Daniel P. O'Day |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,600 |
